𝔖 Scriptorium
✦   LIBER   ✦

πŸ“

Anticoagulants, Antiplatelets, and Thrombolytics: Second Edition

✍ Scribed by Shaker A. Mousa (auth.), Shaker A. Mousa (eds.)


Publisher
Humana Press
Year
2010
Tongue
English
Leaves
322
Series
Methods in Molecular Biology 663
Edition
2
Category
Library

⬇  Acquire This Volume

No coin nor oath required. For personal study only.

✦ Synopsis


During the past decade, remarkable progress has been made in the development of newer drugs to prevent and treat thromboembolic disorders, such as oral direct anti-Xa and anti-IIa antagonists, as well as oral antiplatelet ADP antagonists with rapid onset and offset. In addition, there has been concentrated effort aimed at identifying novel uses of traditional antithrombotic drugs, such as aspirin, heparin, and oral anticoagulants, as well as combinations of agents, such as more than one antiplatelet, antiplatelet with anticoagulant, antiplatelet with or without thrombolytic. Anticoagulants, Antiplatelets, and Thrombolytics, Second Edition provides updates on various strategies in thrombosis, experimental models, and clinical and recent advances in the discovery and development of novel antithrombotics. As a volume in the highly successful Methods in Molecular Biologyβ„’ series, this collection provides the kind of detailed description and implementation advice that is crucial for getting optimal results. Easy to use and up to date, Anticoagulants, Antiplatelets, and Thrombolytics, Second Edition is an ideal guide for researchers aiming for the future of this vital field, focusing on the prevention of thromboembolic disorders and the protection of the vascular endothelium.

✦ Table of Contents


Front Matter....Pages i-xi
Back Matter....Pages 1-28
....Pages 29-107

✦ Subjects


Molecular Medicine; Cardiology


πŸ“œ SIMILAR VOLUMES


Anticoagulants, Antiplatelets, and Throm
✍ Shaker A. Mousa (auth.), Shaker A. Mousa (eds.) πŸ“‚ Library πŸ“… 2004 πŸ› Springer New York 🌐 English

During the past decade, remarkable progress has been made in the development of new drugs to treat thrombotic and cardiovascular diseases, the number one cause of mortality worldwide. In Anticoagulants, Antiplatelets, and Thrombolytics, leading experts with established records of discovery and inven

Anticoagulants, Antiplatelets, and Throm
✍ Shaker A. Mousa πŸ“‚ Library πŸ“… 2010 πŸ› Humana Press 🌐 English

This practical collection provides a comprehensive update on clinically relevant in vitro and in vivo models of thrombosis and hemostasis for the discovery and testing of antithrombotics, and summarizes recent development in pharmaceuticals for the prevention and treatment of various thromboembolic

Anticoagulants, Antiplatelets, and Throm
✍ Shaker A. Mousa πŸ“‚ Library πŸ“… 2003 🌐 English

1This collection of review articles highlights the latest development of antithrombotics and provides proven experimental methods for the further development of new and improved anticoagulants. Among the cutting-edge developments reviewed are the novel usage of low molecular weight heparins, such an

Anticoagulants, Antiplatelets, and Throm
✍ Shaker A. Mousa πŸ“‚ Library πŸ“… 2003 πŸ› Humana Press 🌐 English

Albany College of Pharmacy, New York. Highlights the latest developments in antithrombotics and provides experimental methods for the discovery of new and improved anticoagulants. Presents relevant in vitro and in vivo models in thrombosis and hemostasis. For researchers and clinicians. DNLM: Antico